면역분석법 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global immunoassay market size is expected to reach USD 63.93 Billion in 2034 from USD 38.39 Billion in 2025, growing at a CAGR of 5.83 during 2026-2034.This market is experiencing strong expansion as healthcare providers increasingly rely on immunoassay technologies for accurate disease diagnosis, therapeutic monitoring, and clinical research applications. Immunoassays provide highly sensitive and specific detection of biomarkers associated with infectious diseases, cancer, cardiovascular disorders, endocrine conditions, and autoimmune diseases. Growing emphasis on early disease detection and preventive healthcare is significantly supporting market development worldwide.

Increasing prevalence of chronic diseases, expanding diagnostic testing volumes, and continuous advancements in laboratory automation are major factors driving market growth. Healthcare facilities are adopting advanced immunoassay analyzers capable of delivering rapid, reliable, and high-throughput testing results. Rising investments in diagnostic laboratories, personalized medicine, and biotechnology research are further strengthening demand across hospitals, research institutions, and clinical laboratories.

The future outlook remains highly promising as innovations in molecular diagnostics, point-of-care testing, and artificial intelligence continue improving diagnostic capabilities. Development of highly multiplexed assays, automated laboratory workflows, and next-generation biomarker analysis will enhance testing accuracy and efficiency. Growing healthcare expenditure, expanding disease screening programs, and continuous technological advancements will support sustained long-term expansion across the global immunoassay market.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product & Service

• Reagents & Kits
• Analyzers & Instruments
• Software & Services

By Technology

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Chemiluminescence Immunoassay (CLIA)
• Fluorescence Immunoassay (FIA)
• Radioimmunoassay (RIA)
• Lateral Flow Immunoassay (LFIA)
• Multiplex & Microarray Immunoassays
• Others (Western Blot, Immuno-PCR)

By Application

• Infectious Diseases
• Oncology
• Cardiology
• Endocrinology
• Autoimmune Disorders
• Therapeutic Drug Monitoring
• Drug Discovery & Development
• Others

By Specimen Type

• Blood & Serum
• Saliva
• Urine
• Other Body Fluids

By End User

• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Point-of-Care/Home-Care Settings
• Others

COMPANIES PROFILED

• Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Hologic Inc., Luminex Corporation, QIAGEN N.V., Sysmex Corporation, Agilent Technologies Inc., bioMerieux SA, DiaSorin S.p.A., Ortho Clinical Diagnostics, Tosoh Bioscience Inc., Shenzhen Mindray Bio-Medical, Merck KGaA, QuidelOrtho Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMMUNOASSAY MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Analyzers & Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMMUNOASSAY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Enzyme-Linked Immunosorbent Assay (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chemiluminescence Immunoassay (CLIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Fluorescence Immunoassay (FIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Radioimmunoassay (RIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Lateral Flow Immunoassay (LFIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Multiplex & Microarray Immunoassays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others (Western Blot, Immuno-PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMMUNOASSAY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Endocrinology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Autoimmune Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Therapeutic Drug Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMMUNOASSAY MARKET: BY SPECIMEN TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Specimen Type
• 7.2. Blood & Serum Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Saliva Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Body Fluids Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IMMUNOASSAY MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Point-of-Care/Home-Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL IMMUNOASSAY MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product & Service
  • 9.2.2 By Technology
  • 9.2.3 By Application
  • 9.2.4 By Specimen Type
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product & Service
  • 9.3.2 By Technology
  • 9.3.3 By Application
  • 9.3.4 By Specimen Type
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product & Service
  • 9.4.2 By Technology
  • 9.4.3 By Application
  • 9.4.4 By Specimen Type
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product & Service
  • 9.5.2 By Technology
  • 9.5.3 By Application
  • 9.5.4 By Specimen Type
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product & Service
  • 9.6.2 By Technology
  • 9.6.3 By Application
  • 9.6.4 By Specimen Type
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL IMMUNOASSAY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 F. Hoffmann-La Roche AG
  • 11.2.3 Siemens Healthineers AG
  • 11.2.4 Danaher Corporation
  • 11.2.5 Thermo Fisher Scientific Inc
  • 11.2.6 Becton Dickinson And Company
  • 11.2.7 Bio-Rad Laboratories Inc
  • 11.2.8 Hologic Inc
  • 11.2.9 Luminex Corporation
  • 11.2.10 QIAGEN N.V
  • 11.2.11 Sysmex Corporation
  • 11.2.12 Agilent Technologies Inc
  • 11.2.13 BioM erieux SA
  • 11.2.14 DiaSorin S.p.A
  • 11.2.15 Ortho Clinical Diagnostics
  • 11.2.16 Tosoh Bioscience Inc
  • 11.2.17 Shenzhen Mindray Bio-Medical
  • 11.2.18 Merck KGaA
  • 11.2.19 QuidelOrtho Corporation